Sabine Zitzmann-Kolbe

8PUBLICATIONS
37CO-AUTHORS
Instruments and techniquesRadiation therapyPharmaceutical delivery technologiesMolecular targetsAccelerators
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 01, 2025
Biodistribution of free Francium-221 and Bismuth-213 in Tumour-bearing SCID mice after successful development of Actinium-225/Francium-221 radionuclide generator Set-up.

Sabine Zitzmann-Kolbe, Yvonne Remde, Ingrid Moen

|Apr 09, 2024
Preclinical Efficacy of a PSMA-Targeted Actinium-225 Conjugate (225Ac-Macropa-Pelgifatamab): A Targeted Alpha Therapy for Prostate Cancer.

Christoph A Schatz, Sabine Zitzmann-Kolbe, Ingrid Moen

|Oct 26, 2023
Mono- and multimeric PSMA-targeting small molecule-thorium-227 conjugates for optimized efficacy and biodistribution in preclinical models.

Niels Böhnke, Bård Indrevoll, Stefanie Hammer

|Jun 26, 2023
A Targeted Thorium-227 Conjugate Demonstrates Efficacy in Preclinical Models of Acquired Drug Resistance and Combination Potential with Chemotherapeutics and Antiangiogenic Therapies.

Sabine Zitzmann-Kolbe, Alexander Kristian, Dieter Zopf

|Dec 02, 2021
DNA repair inhibitors sensitize cells differently to high and low LET radiation.

Kristina Bannik, Balázs Madas, Sabrina Jarke

|May 26, 2021
Darolutamide Potentiates the Antitumor Efficacy of a PSMA-targeted Thorium-227 Conjugate by a Dual Mode of Action in Prostate Cancer Models.

Stefanie Hammer, Andreas Schlicker, Sabine Zitzmann-Kolbe

Pageof 2

Frequent Collaborators

3 joint publications

Stefanie Hammer

3 joint publications

Jenny Karlsson

3 joint publications

Urs B Hagemann

2 joint publications

Balázs Madas